A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma.
Sohal DP, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ, Carberry M, Wissel P, Jacobs-Small M, O'Dwyer PJ, Sepulveda A, Sun W.
Sohal DP, et al. Among authors: giantonio bj.
Ann Oncol. 2013 Dec;24(12):3061-5. doi: 10.1093/annonc/mdt416. Epub 2013 Oct 20.
Ann Oncol. 2013.
PMID: 24146220
Free article.
Clinical Trial.